An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...

The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to high-risk adults as young as 50, too. But the CDC lacks a director to decide ...

Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update ...

RSV jab in pregnancy can ‘significantly’ cut baby’s infection risk, study says - Vaccinating pregnant women against RSV will ‘significantly’ reduce the risk their babies being hospitalised ...

Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a recent CDC update.

RSV vaccine access expanded to some people in their 50s, according to CDC website The decision appears on a CDC webpage but wasn’t on the agency’s official adult immunization schedule.